J&J's Levaquin wins US FDA nod for use in plague
This article was originally published in Scrip
Executive Summary
The US FDA approved Johnson & Johnson's fluoroquinolone Levaquin (levofloxacin) for an indication for which the US government is hoping will not widely be used: plague.